title: Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.
authors.forename: Hendrée E
authors.initials: HE
authors.lastname: Jones
authors.forename: Sarah H
authors.initials: SH
authors.lastname: Heil
authors.forename: Karol
authors.initials: K
authors.lastname: Kaltenbach
authors.forename: Susan M
authors.initials: SM
authors.lastname: Stine
authors.forename: Mara G
authors.initials: MG
authors.lastname: Coyle
authors.forename: Amelia M
authors.initials: AM
authors.lastname: Arria
authors.forename: Kevin E
authors.initials: KE
authors.lastname: O'Grady
authors.forename: Peter
authors.initials: P
authors.lastname: Selby
authors.forename: Peter R
authors.initials: PR
authors.lastname: Martin
mesh_terms: D002047:Buprenorphine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008691:Methadone / Q000627:therapeutic use*; D058850:Opiate Substitution Treatment / Q000523:psychology*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*
chemical_list: D002047:Buprenorphine; D008691:Methadone